Keeps Biopharma Inc. (KOSDAQ:256940)

South Korea · Delayed Price · Currency is KRW

8,460.00

-130.00 (-1.51%)

At close: Apr 17, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Recycling			81.63B	-	-	-	-
OLED Business			4.58B	-	-	-	-
Pharmaceutical and Bio Business			6.39B	-	-	-	-
Cross-segment Profits			-468.46M	-	-	-	-
Industrial Automation & Controls			-	14.62B	4.26B	15.22B	14.19B
Industrial Automation & Controls Growth			-	243.08%	-72.00%	7.23%	-65.07%
Total			92.13B	14.62B	4.26B	15.22B	14.19B
Total Growth			530.30%	243.08%	-72.00%	7.23%	-65.07%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea			90.16B	14.26B	3.40B	1.77B	416.00M
South Korea Growth			532.19%	319.38%	92.62%	324.37%	-85.84%
China			1.97B	339.36M	575.52M	13.30B	12.34B
China Growth			481.81%	-41.03%	-95.67%	7.77%	-64.69%
Other			-	16.65M	284.44M	148.46M	1.43B
Other Growth			-	-94.15%	91.60%	-89.63%	-47.68%
Total			92.13B	14.62B	4.26B	15.22B	14.19B
Total Growth			530.30%	243.08%	-72.00%	7.23%	-65.07%

Source: S&P Global Market Intelligence.